User menu

Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.

Bibliographic reference Bachy, Emmanuel ; Estell, Jane A ; Van Den Neste, Eric ; Bouabdallah, Réda ; Bargay, Joan ; et. al. Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study.. In: American Journal of Hematology, Vol. 91, no.4, p. 410-415 (2016)
Permanent URL http://hdl.handle.net/2078.1/184843
  1. Solal-Céligny Philippe, Bellei Monica, Marcheselli Luigi, Pesce Emanuela Anna, Pileri Stefano, McLaughlin Peter, Luminari Stefano, Pro Barbara, Montoto Silvia, Ferreri Andrés J.M., Deconinck Eric, Milpied Noël, Gordon Leo I., Federico Massimo, Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database, 10.1200/jco.2010.33.4474
  2. Horning, Semin Oncol, 20, 75 (1993)
  3. Press Oliver W., Unger Joseph M., Rimsza Lisa M., Friedberg Jonathan W., LeBlanc Michael, Czuczman Myron S., Kaminski Mark, Braziel Rita M., Spier Catherine, Gopal Ajay K., Maloney David G., Cheson Bruce D., Dakhil Shaker R., Miller Thomas P., Fisher Richard I., Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016, 10.1200/jco.2012.42.4101
  4. Gallagher C J, Gregory W M, Jones A E, Stansfeld A G, Richards M A, Dhaliwal H S, Malpas J S, Lister T A, Follicular lymphoma: prognostic factors for response and survival., 10.1200/jco.1986.4.10.1470
  5. Hainsworth, Blood, 95, 3052 (2000)
  6. Herold Michael, Haas Antje, Srock Stefanie, Neser Sabine, Al-Ali Kathrin Haifa, Neubauer Andreas, Dölken Gottfried, Naumann Ralph, Knauf Wolfgang, Freund Mathias, Rohrberg Robert, Höffken Klaus, Franke Astrid, Ittel Thomas, Kettner Erika, Haak Ursula, Mey Ulrich, Klinkenstein Christian, Aβmann Michael, von Grünhagen Ullrich, Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study, 10.1200/jco.2006.06.4618
  7. Hiddemann W., Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group, 10.1182/blood-2005-01-0016
  8. Liu Qi, Fayad Luis, Cabanillas Fernando, Hagemeister Fredrick B., Ayers Gregory D., Hess Mark, Romaguera Jorge, Rodriguez M. Alma, Tsimberidou Apostolia M., Verstovsek Srdan, Younes Anas, Pro Barbara, Lee Ming-Sheng, Ayala Ana, McLaughlin Peter, Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center, 10.1200/jco.2005.03.3696
  9. Salles G., Mounier N., de Guibert S., Morschhauser F., Doyen C., Rossi J.-F., Haioun C., Brice P., Mahe B., Bouabdallah R., Audhuy B., Ferme C., Dartigeas C., Feugier P., Sebban C., Xerri L., Foussard C., Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study, 10.1182/blood-2008-04-153189
  10. Swenson Wade T., Wooldridge James E., Lynch Charles F., Forman-Hoffman Valerie L., Chrischilles Elizabeth, Link Brian K., Improved Survival of Follicular Lymphoma Patients in the United States, 10.1200/jco.2005.04.503
  11. Hochster Howard, Weller Edie, Gascoyne Randy D., Habermann Thomas M., Gordon Leo I., Ryan Theresa, Zhang Lijun, Colocci Natalia, Frankel Stanley, Horning Sandra J., Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study, 10.1200/jco.2008.17.1561
  12. Bachy E., Houot R., Morschhauser F., Sonet A., Brice P., Belhadj K., Cartron G., Audhuy B., Ferme C., Feugier P., Sebban C., Delwail V., Maisonneuve H., Le Gouill S., Lefort S., Brousse N., Foussard C., Salles G., , Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma, 10.3324/haematol.2012.082412
  13. Bachy Emmanuel, Brice Pauline, Delarue Richard, Brousse Nicole, Haioun Corinne, Le Gouill Steven, Delmer Alain, Bordessoule Dominique, Tilly Hervé, Corront Bernadette, Allard Christian, Foussard Charles, Bosly André, Coiffier Bertrand, Gisselbrecht Christian, Solal-Celigny Philippe, Salles Gilles, Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude des Lymphomes de l'Adulte, 10.1200/jco.2009.22.7819
  14. Gopal Ajay K., Kahl Brad S., de Vos Sven, Wagner-Johnston Nina D., Schuster Stephen J., Jurczak Wojciech J., Flinn Ian W., Flowers Christopher R., Martin Peter, Viardot Andreas, Blum Kristie A., Goy Andre H., Davies Andrew J., Zinzani Pier Luigi, Dreyling Martin, Johnson Dave, Miller Langdon L., Holes Leanne, Li Daniel, Dansey Roger D., Godfrey Wayne R., Salles Gilles A., PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma, 10.1056/nejmoa1314583
  15. Radford J., Davies A., Cartron G., Morschhauser F., Salles G., Marcus R., Wenger M., Lei G., Wassner-Fritsch E., Vitolo U., Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000), 10.1182/blood-2013-01-481341
  16. Nielsen Sune F., Nordestgaard Børge G., Bojesen Stig E., Statin Use and Reduced Cancer-Related Mortality, 10.1056/nejmoa1201735
  17. Eisenberg Daniel A, Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent Trials, 10.1016/s0002-9343(98)00038-2
  18. Yu Oriana, Eberg Maria, Benayoun Serge, Aprikian Armen, Batist Gerald, Suissa Samy, Azoulay Laurent, Use of Statins and the Risk of Death in Patients With Prostate Cancer, 10.1200/jco.2013.49.4757
  19. Winiarska Magdalena, Bil Jacek, Wilczek Ewa, Wilczynski Grzegorz M, Lekka Malgorzata, Engelberts Patrick J, Mackus Wendy J. M, Gorska Elzbieta, Bojarski Lukasz, Stoklosa Tomasz, Nowis Dominika, Kurzaj Zuzanna, Makowski Marcin, Glodkowska Eliza, Issat Tadeusz, Mrowka Piotr, Lasek Witold, Dabrowska-Iwanicka Anna, Basak Grzegorz W, Wasik Maria, Warzocha Krzysztof, Sinski Maciej, Gaciong Zbigniew, Jakobisiak Marek, Parren Paul W. H. I, Golab Jakub, Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20, 10.1371/journal.pmed.0050064
  20. Winiarska Magdalena, Nowis Dominika, Bil Jacek, Glodkowska-Mrowka Eliza, Muchowicz Angelika, Wanczyk Malgorzata, Bojarczuk Kamil, Dwojak Michal, Firczuk Malgorzata, Wilczek Ewa, Wachowska Malgorzata, Roszczenko Katarzyna, Miaczynska Marta, Chlebowska Justyna, Basak Grzegorz Wladyslaw, Golab Jakub, Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity, 10.1074/jbc.m112.374751
  21. Nowakowski Grzegorz S., Maurer Matthew J., Habermann Thomas M., Ansell Stephen M., Macon William R., Ristow Kay M., Allmer Cristine, Slager Susan L., Witzig Thomas E., Cerhan James R., Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era, 10.1200/jco.2009.23.4245
  22. Samaras Panagiotis, Heider Helen, Haile Sarah R., Petrausch Ulf, Schaefer Niklaus G., Siciliano Raffaele Daniele, Meisel Alexander, Mischo Axel, Zweifel Martin, Knuth Alexander, Stenner-Liewen Frank, Renner Christoph, Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP, 10.1007/s00277-010-0926-0
  23. Chae Y. K., Trinh L., Jain P., Wang X., Rozovski U., Wierda W. G., Keating M. J., Estrov Z., Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia, 10.1182/blood-2013-07-517102
  24. Salles Gilles, Seymour John Francis, Offner Fritz, López-Guillermo Armando, Belada David, Xerri Luc, Feugier Pierre, Bouabdallah Réda, Catalano John Vincent, Brice Pauline, Caballero Dolores, Haioun Corinne, Pedersen Lars Moller, Delmer Alain, Simpson David, Leppa Sirpa, Soubeyran Pierre, Hagenbeek Anton, Casasnovas Olivier, Intragumtornchai Tanin, Fermé Christophe, da Silva Maria Gomes, Sebban Catherine, Lister Andrew, Estell Jane A, Milone Gustavo, Sonet Anne, Mendila Myriam, Coiffier Bertrand, Tilly Hervé, Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial, 10.1016/s0140-6736(10)62175-7
  25. Cheson Bruce D., Pfistner Beate, Juweid Malik E., Gascoyne Randy D., Specht Lena, Horning Sandra J., Coiffier Bertrand, Fisher Richard I., Hagenbeek Anton, Zucca Emanuele, Rosen Steven T., Stroobants Sigrid, Lister T. Andrew, Hoppe Richard T., Dreyling Martin, Tobinai Kensei, Vose Julie M., Connors Joseph M., Federico Massimo, Diehl Volker, Revised Response Criteria for Malignant Lymphoma, 10.1200/jco.2006.09.2403
  26. Jakobisiak, Int J Oncol, 23, 1055 (2003)
  27. Qi X-F, Zheng L, Lee K-J, Kim D-H, Kim C-S, Cai D-Q, Wu Z, Qin J-W, Yu Y-H, Kim S-K, HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway, 10.1038/cddis.2013.44
  28. Malenda Agata, Skrobanska Anna, Issat Tadeusz, Winiarska Magdalena, Bil Jacek, Oleszczak Bozenna, Sinski Maciej, Firczuk Małgorzata, Bujnicki Janusz M., Chlebowska Justyna, Staruch Adam D., Glodkowska-Mrowka Eliza, Kunikowska Jolanta, Krolicki Leszek, Szablewski Leszek, Gaciong Zbigniew, Koziak Katarzyna, Jakobisiak Marek, Golab Jakub, Nowis Dominika A., Statins Impair Glucose Uptake in Tumor Cells, 10.1593/neo.12444
  29. Mann Devin, Reynolds Kristi, Smith Donald, Muntner Paul, Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines, 10.1345/aph.1l181
  30. Ennishi D., Asai H., Maeda Y., Shinagawa K., Ikeda K., Yokoyama M., Terui Y., Takeuchi K., Yoshino T., Matsuo K., Hatake K., Tanimoto M., Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy, 10.1093/annonc/mdp490